Smouldering myeloma: detection, risk stratification and defining a new standard of care
The GALLIUM study
Nivolumab in combination with azacitidine in patients with relapsed acute myeloid leukemia (AML)
Naval G. Daver
Case study: daratumumab in a relapsed patient
Is an early diagnosis of CLL beneficial in its treatment?